(NewsDirect)
Eden Research PLC CEO Sean Smith joinedProactive's Stephen Gunnion with news that the company has gainedregulatory approval for its Novellus biofungicide in New Zealand.Smith said New Zealand's grape production and climatic conditionsmake it an important market for Eden, as Novellus effectively targetsfungal diseases.
This follows newsof recent approvals in California and Florida in the United Statesafter it received regulatory authorisation from the US EnvironmentalProtection Agency in September 2022. Smith said he anticipates futureauthorisations from ongoing review processes in California and CentralEurope.
Contact Details
Proactive UKLtd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.